Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 6 publications
Salivary metabolomics for early detection of vascular contributions to cognitive impairment and dementia: Exploring microbiome dysbiosis and sex differences.
Journal: Journal of Alzheimer's disease : JAD
Published: March 16, 2026
Urinary Cytokines as Potential Biomarkers of Mild Cognitive Impairment and Alzheimer's Disease: A Pilot Study.
Journal: Journal of Alzheimer's disease reports
Published: October 06, 2022
Targeted Metabolic Profiling of Urine Highlights a Potential Biomarker Panel for the Diagnosis of Alzheimer's Disease and Mild Cognitive Impairment: A Pilot Study.
Journal: Metabolites
Published: July 09, 2020
Diagnostic Biomarkers of Alzheimer's Disease as Identified in Saliva using 1H NMR-Based Metabolomics.
Journal: Journal of Alzheimer's disease : JAD
Published: April 29, 2017
Case report: Hypopituitarism masquerading as failure to thrive in a 75-year-old woman.
Journal: Journal of the American Geriatrics Society
Published: October 22, 2014
Showing 1-6 of 6
Last Updated: 09/26/2026